ABCL vs VRTX: Which Stock is Better?
Side-by-side comparison of Abcellera Biologics Inc and Vertex Pharmaceuticals Inc in 2026
ABCL
Abcellera Biologics Inc
—
VRTX
Vertex Pharmaceuticals Inc
$485.39
Key Metrics Comparison
| Metric | ABCL | VRTX | Winner |
|---|---|---|---|
| Market Cap | $1.12B | $106.87B | VRTX |
| P/E Ratio | N/A | 29.67 | VRTX |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABCL
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABCL or VRTX a better investment?
Comparing ABCL and VRTX: Abcellera Biologics Inc has a market cap of $1.12B while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABCL and VRTX?
ABCL (Abcellera Biologics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABCL or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABCL or VRTX?
Both ABCL and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABCL or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABCL or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $1.12B for ABCL.
Should I buy ABCL or VRTX in 2026?
Both ABCL and VRTX have investment merit. ABCL trades at $N/A while VRTX trades at $485.39. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABCL and VRTX stock?
Key differences: Market Cap ($1.12B vs $106.87B), P/E Ratio (N/A vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABCL or VRTX in 2026?
The choice between ABCL and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABCL and VRTX?
ABCL (Abcellera Biologics Inc) has a market cap of $1.12B, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.